FAPA holds 28th Congress in Kuala Lumpur
January 3, 2023
Back-to-Back MOA Signing for 2023 and 2024 FAPA Congress
January 6, 2023

FAPA Welcomes Federation of Taiwan Pharmacists Association as New Member Association

KUALA LUMPUR, MALAYSIA  – The Federation of Asian Pharmaceutical Associations (FAPA) has officially welcomed the Federation of Taiwan Pharmacists Associations (FTPA) as its newest member association. The decision was made during the Closed Council Meeting on November 8, 2022, at the Kuala Lumpur Convention Centre, where the council approved FTPA’s application.

FTPA was established in 1980 and is the largest pharmacist organization in Taiwan, with over 33,000 pharmacist members through local pharmacist associations. The organization is dedicated to promoting the professional development of pharmacists, improving healthcare service quality, and enhancing the public’s welfare.

During the COVID-19 pandemic, FTPA played an essential role in responding to the crisis. Through its network of over 8,000 community pharmacies, FTPA facilitated the rationing and delivery of facemasks, rapid antigen test kits, and medicines. The organization is also looking forward to providing more services for long-term care and pharmaceutical care in the future.

At the opening ceremony of the 28th FAPA Congress, FTPA was recognized and awarded a certificate of membership, officially welcoming them to the FAPA family. FAPA President, Dr. Yolanda Robles, handed FTPA President Mr. Chin-shun Huang a FAPA ribbon as a gesture of welcome.

The addition of FTPA to FAPA’s network is a significant milestone for the organization, as it strengthens its presence in Taiwan and the Asian pharmaceutical industry. FTPA will now have access to a broader network of pharmaceutical associations in Asia through FAPA, which will enable them to collaborate with other industry players, share best practices, and stay updated with the latest trends and developments in the industry.

With its extensive experience and knowledge of the pharmaceutical industry in Taiwan, FTPA will be a valuable addition to FAPA’s network. The organization’s knowledge and expertise will help FAPA understand the challenges and opportunities facing the pharmaceutical industry in Taiwan and other parts of Asia.

In conclusion, the addition of FTPA to FAPA’s membership is a positive development for the pharmaceutical industry in Taiwan and the Asia Pacific region. The partnership between the two organizations will bring more collaboration and innovation in the industry, ultimately benefiting patients and healthcare providers across the region.

Katrina Herrera
Author: Katrina Herrera

Comments are closed.